17th Annual European Life Sciences CEO Forum 2024 | Sachs Associates Ltd | 27 February 2024 | Hilton Zurich Airport Hotel, Hilton Zurich Airport Hote

The success and longevity of the forum is built on the goodwill and repeat attendance of major corporate and financial investors, and pharma licensing executives and advisors, who are seeking to network with biotechs. The programme and presentations allow all to keep up with the latest industry developments and strategize for 2024. The physical programme will consist of the usual panels and keynotes, which will be available on demand from the 6th of March. Additionally, there will be pre-arranged in-person meetings, live and on demand company showcases and a reception. During the online week, virtual meetings will be available through the audio/video online meeting system.

The main programme for the event is spread throughout 2 days and will feature more than 12 hours of high-level keynotes and panel discussions. In addition, there will be a global company showcase of 50+ presentations by established public, private, emerging and seed companies, offering innovative solutions and seeking investment and partnering opportunities. This will include a limited number of live presentations taking place in dedicated presentation tracks, alongside virtual company showcases, which will be available on demand during the virtual week. We anticipate 400+ delegates will register for the forum from all Life Sciences sectors, with the target audience being corporate and financial investors/partners, banks and advisors with part of the audience participating virtually.

2024 Speakers

KEYNOTE SPEAKERS:

Chris Roberts
Head of EMEA Issuer Services, Hong Kong Exchanges and Clearing Limited

Liesbeth Ceelen
CEO, Biolizard SA

Matthias Tschöp
Chief Executive Officer & Chief Scientific Officer, Helmholtz Munic

CHAIRS AND SPEAKERS:

Alessandra Polara
Senior Director, Global BD, F. Hoffmann-La Roche AG

Allan Marchington
Managing Director, Head of Life Sciences, Intermediate Capital Group PLC

Andreas Jurgeit
Partner, Gimv

Andreas Pahl
CEO, Heidelberg Pharma AG

Andreas Wallnoefer
Partner, Jeito Capital

Anna Lisa Picciolo-Lehrke
Head Business Development Neurology, UCB Pharma

Antoine Boulanger
Principal, Forbion

Apollon Papadimitriou
CEO, iOmx Therapeutics AG

Aram Mangasarian
CEO, TME Pharma

Astrid Maria Dahl
COO & Head of Europe, Innovent Biologics

Asun Monfort
Investment Advisor, HBM Partners AG

Benjamin Thomas
Senior Vice President - Operations, Oxford BioTherapeutics Ltd.

Carlos Buesa
Founder & CEO, Oryzon Genomics, S.A.
​
Christian Thomsen
Global Head, CNS BD&L, Boehringer
Ingelheim International GmbH

Dani Bach
Partner, +ND Capital

Daniel Parera
Partner, Kurma Partners

Diana Saraceni
Co-Founder & General Partner, Panakès Partners SGR SpA

Donald Xu
Managing Partner, Lynx Financial Hong Kong Ltd.

Dragan Grabulovski
Acting CEO, Araris Biotech AG

Edouard Caram
Sr Director, Global Partnership Rare Diseases & Neurosciences, Ipsen

Emin Fadillioglu
CEO, Eczacibasi Pharmaceutical and Industrial Investment Co.

Eric Halioua
President & CEO, PDC*line Pharma SA

Esteban Pombo-Villar
CTO, TargImmune Therapeutics AG

Evonne Sepsis
Managing Director, ESC Advisors

Francois Ravenelle
Founder & CEO, Inversago Pharma

François Thomas
Operating Partner, Quadrille Capital

Georgia Frost
Senior Associate, Dementia Discovery Fund - SV Health Investors LLP

Göran Forsberg
CEO, Cantargia AB
Hakan Goker, Managing Director, M Ventures

Helen Chen
Global Sector Co-Head, Healthcare & Life Sciences Greater China Managing Partner, L.E.K. Consulting

Hemant Sabherwal
Senior Vice President, Global Issuer Services, Hong Kong Exchanges and Clearing Limited

Jesus Baena
BD&L Transactions Director, Novartis AG

Joachim Vogt
Director Search & Evaluation International, AbbVie, Inc.

Jonathan Tobin
Partner, Brandon Capital

Josua Jordi
Co-Founder & CEO, EraCal Therapeutics Ltd.

Katya Smirnyagina
Senior Partner, Oxford Science Enterprises

Kelly Curtin
Managing Director, Stifel

Khatereh Ahmadi
Head of Search & Evaluation Business Development, Europe & Middle East, MSD

Klaus Breiner
Managing Partner, Pureos Bioventures

Klaus Dugi
CEO, Vandria SA

Konstantin Petropoulos
CBO & Managing Director, Secarna Pharmaceuticals GmbH & Co. KG

Lubor Gaal
CFO & Head of BD & Alliance Management, Circio Holding ASA

Marc Ditmarsch
Chief Development Officer,
NewAmsterdam Pharma

Marc Robillard
CEO, Tagworks Pharmaceuticals BV

Marie Leblanc
Executive Director, Lonza AG

Marine Beurdeley
Senior Director, Global Business Development, Ipsen

Mark Rayner
Managing Partner, GOLDTRACK Ventures GmbH

Michael Altorfer
CEO, Swiss Biotech Association

Michael Hübner
Director Early Innovation Partnering, Johnson & Johnson Innovation LLC

Nathalie ter Wengel
European Lead, Worldwide Business Development, Pfizer, Inc.

Naveed Siddiqi
Senior Partner, Novo Holdings A/S

Nigel Sheail
Venture Partner, Versant Ventures

Olav Zilian
Senior Equity Analyst - Healthcare, Pictet & Cie SA

Paul Hermant
Partner, Bird & Bird LLP

Peter Braun
CEO, TargImmune Therapeutics AG

Philip Larsen
CEO, SixPeaks Bio

Rianne Ellenbroek
Principal, BioGeneration Ventures

Richard Ward
Executive Director, Search & Evaluation, AstraZeneca

Sandra von Meier
Head Business Development & Licensing, Debiopharm International SA

Sarah Holland
CBO of Cureteq AG & President, Swiss Healthcare Licensing Group

Sascha Berger
Partner, TVM Capital Life Science

Simon Chandler
CEO, Rinri Therapeutics Ltd.

Søren Møller
Managing Partner, Novo Holdings A/S

Stacy Lindborg
Co-CEO, Brainstorm Cell Therapeutics, Inc.

Stefano Portolano
CEO, Azafaros Switzerland AG

Stephan Lensky
COO & CBO, EpimAb Biotherapeutics

Stephanie Léouzon
Managing Director, Stifel

Stephen Doyle
Chief Business Officer, Aslan Pharmaceuticals

Stephen Myatt
CEO, Macomics Ltd.

Stephen Squinto
Chief Investment Officer, J.P.
Morgan Life Sciences Private Capital

Susan Hill
CEO, Mestag Therapeutics Ltd.

Tamas Schweighoffer
Co-Founding Partner, Forty51 Ventures AG

Tom Shepherd
CEO, Captor Therapeutics S.A.

Tomas Landh
Innovation Sourcing VP, Senior Principal Scientist R&D Global Search & Evaluation, Novo Nordisk A/S

Ulrich Wendt
Global Head Business Development Immunology & Inflammation, Sanofi

Victoria English
Co-Founder & Editor of Evernow Publishing Ltd, publisher, MedNous

2024 Sponsors

SILVER SPONSOR:
• STIFEL

BRONZE SPONSORS:
• BIOSAXONY
• InvestHK

CONTRIBUTING SPONSOR:
• Novo Holdings